DRIM-Nail System
41Medical AG · Decision date Sep 11, 2026
What did the FDA decide?
The FDA's 510(k) database records K260115 for the DRIM-Nail System, submitted by 41Medical AG of Bettlach, Switzerland, with Alfred Niederberger listed as applicant contact and Mcra, LLC as correspondent. The record shows a receipt date of 01/14/2026 and a decision date of 09/11/2026, with the review panel listed as Orthopedic and the submission type as Traditional.
The decision is Substantially Equivalent (SESE), which is a 510(k) clearance rather than a premarket approval. The record states the device was not reviewed by a third party, is not a combination product, and has no authorized Predetermined Change Control Plan. The specialty field is recorded as Unknown, and the available material does not describe the device's components, materials, indications for use, or predicate devices, so those details remain unverified here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Unknown
- Decision date
- Sep 11, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260115
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- 41Medical AG
- Product code
- Not reported
- Decision code
- SESE
- Decision date
- Sep 11, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
- Applicant
- 41Medical AG
- Product code
- Not reported
FDA decision timeline
K260115 received
Application receipt date recorded by FDA.
K260115 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
41Medical AG
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Bettlach
Sources and methodology
- Original FDA record: K260115
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records